News | Academics

Columbia scientists’ research confirms feasibility of human embryo genome editing, raises ethics questions

Development cell biologist Dieter Egli’s latest paper reveals that base editing, an alternative to CRISPR-Cas, can make targeted changes to the genomes of human embryos.

By Tori Fergus / A&C Photo Deputy
The findings of the research are not predicted to be commercialized over the next decade.
By Lara Harmankaya and Jessica Singh • June 30, 2026 at 3:19 AM